Elevated glutamate and lactate predict brain death after severe head trauma

Area of Science:

• Neuroscience
• Biomarkers
• Trauma Care

Background:

• Clinical neurological assessment is difficult in acute severe traumatic brain injury (TBI).
• Neurochemical changes following TBI may serve as fluid biomarkers.
• Cerebrospinal fluid (CSF) analysis offers a window into the brain's biochemical state.

Purpose of the Study:

• To investigate cerebrospinal fluid (CSF) levels of glutamate, lactate, BDNF, and GDNF.
• To identify prognostic biomarkers for neurological outcomes in severe TBI patients.
• To correlate early CSF neurochemical profiles with short-term survival.

Main Methods:

• Cross-sectional study of 20 severe TBI patients (GCS ≤ 8) with abnormal CT scans.
• CSF collected 2-4 hours post-admission via ventricular drainage.
• Patients stratified into nonsurvival (n=6) and survival (n=14) groups within 3 days.

Main Results:

• Significantly higher CSF glutamate and lactate levels in nonsurvival versus survival groups.
• Glutamate sensitivity 80.0%, specificity 84.62% (cutoff >57.75); Lactate sensitivity 100%, specificity 85.71% (cutoff >4.65).
• BDNF and GDNF levels did not differentiate between poor and good outcomes.

Conclusions:

• Early CSF glutamate and lactate concentrations accurately predict 3-day mortality in severe TBI.
• These neurochemicals show potential as early prognostic biomarkers for TBI.
• Further research is warranted to validate these findings in larger cohorts.